June 2026
NEW ORLEANS, LA — In a recent episode of NOLA Now, internationally recognized Hyperbaric Medicine specialist Dr. Paul Harch, M.D. joined Katie Murphy, Media Executive with Fox 8 New Orleans, for an in-depth discussion about Hyperbaric Oxygen Therapy (HBOT), its medical applications, and its growing role in modern healthcare.
The interview explored how HBOT works, the science behind oxygen-based healing, and the expanding body of research supporting hyperbaric medicine for various neurological, inflammatory, and recovery-related conditions.
Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that delivers oxygen at increased atmospheric pressure inside a specialized chamber. This process allows significantly higher concentrations of oxygen to dissolve into the bloodstream and tissues, supporting the body’s natural healing mechanisms.
According to Dr. Harch, oxygen is not merely a life-sustaining gas—it also functions as a powerful biological signaling molecule that can stimulate repair processes throughout the body.
During the interview, Dr. Harch explained that HBOT may help:
These effects have made HBOT an area of growing interest among physicians, researchers, and patients seeking additional treatment options for complex health conditions.
Dr. Paul Harch is widely recognized as one of the pioneers in the field of Hyperbaric Medicine. Throughout his career, he has conducted extensive research and treated thousands of patients using HBOT protocols designed to support healing and recovery.
His work has contributed significantly to the understanding of how oxygen under pressure can influence cellular function, neuroplasticity, and tissue repair.
As scientific understanding continues to evolve, researchers are investigating the potential benefits of HBOT in a variety of clinical settings. Studies have examined its use for wound care, neurological recovery, traumatic injuries, and other conditions where tissue oxygenation and healing play important roles.
While research is ongoing, the increasing interest in hyperbaric medicine reflects a broader effort within healthcare to explore therapies that leverage the body’s natural repair mechanisms.
Dr. Paul Harch and other hyperbaric physicians often discuss research involving HBOT for conditions that are not currently FDA-approved indications, including:
These uses may be considered investigational, off-label, or supported by varying levels of clinical evidence depending on the condition and treatment center.
View the complete NOLA Now interview featuring Dr. Paul Harch, M.D. and Katie Murphy to learn more about the science, history, and future of Hyperbaric Oxygen Therapy.